Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical efficacy and histological changes with omalizumab in corticosteroid-dependent allergic asthmatics (GINA Step V)
2009-010914-31Phase 4Completed
- Sponsor
- Dr. Christian Domingo
- Start
- Oct 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of omalizumab in allergic asthma and asthma, sponsored by Dr. Christian Domingo. Primary endpoints: Reduction in oral corticosteroid dose and Pulmonary function tests (forced spirometry). Started Oct 2009; status: completed.
02
Drugs
omalizumab
03
Conditions
allergic asthmaasthma
Beyond the preview
Go deeper on 2009-010914-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010914-31.